Novo to launch Ozempic pill for diabetes in second quarter of 2026

Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...

Ozempic Maker Faces Rocky Financial Forecast. But It’s Good News for Consumers

After making a deal with the Trump administration to lower prices of GLP-1s, Wegovy and Ozempic maker Novo Nordisk expects a drop in revenue for 2026. The decline comes amid higher competition and ...

Novo Nordisk stock extends losses as Ozempic maker sees sales falling in 2026

The Ozempic and Wegovy maker reports full-year sales of 309.1 billion Danish krone, beating analysts’ forecasts.

Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the ...

Trump administration announces 15 new drugs for Medicare price negotiation program

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Ozempic and Semaglutide: Dietitian explains everything you should know about weight loss drugs

Ozempic, a semaglutide drug originally developed for type-2 diabetes, has been in the news as a fast-track weight-loss solution. A former AIIMS dietitian, took to X (twitter) to reveal that while ...

How can I get an Ozempic prescription for weight loss?

How to Get Prescribed Ozempic for Weight Loss This article was reviewed by Lynn Marie Morski, MD, JD Ozempic is FDA-approved for type 2 diabetes but sometimes prescribed ...